<?xml version="1.0" encoding="UTF-8"?>
<ref id="B8-viruses-12-00838">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Brooks</surname>
    <given-names>K.M.</given-names>
   </name>
   <name>
    <surname>Sherman</surname>
    <given-names>E.M.</given-names>
   </name>
   <name>
    <surname>Egelund</surname>
    <given-names>E.F.</given-names>
   </name>
   <name>
    <surname>Brotherton</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Durham</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Badowski</surname>
    <given-names>M.E.</given-names>
   </name>
   <name>
    <surname>Cluck</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Badowksi</surname>
    <given-names>M.E.</given-names>
   </name>
  </person-group>
  <article-title>Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?</article-title>
  <source>Pharmacother. J. Hum. Pharmacol. Drug Ther.</source>
  <year>2019</year>
  <volume>39</volume>
  <fpage>576</fpage>
  <lpage>598</lpage>
  <pub-id pub-id-type="doi">10.1002/phar.2246</pub-id>
 </element-citation>
</ref>
